| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M E K Wahba, D El Wasseef, D El Sherbin. Studying the suitability of hybrid micelle liquid chromatography for estimating the lipophilicity of some partial dopamine agonists used to attain the reward circuit. Royal Society open science. vol 8. issue 5. 2021-06-05. PMID:34084546. |
three micellar-based mobile phases were developed and optimized for the simultaneous determination of certain partial dopamine agonists that are used to overcome the withdrawal symptoms of abused drugs, namely aripiprazole, pramipexole and piribedil. |
2021-06-05 |
2023-08-13 |
Not clear |
| Javier Labad, Itziar Montalvo, Alexandre González-Rodríguez, Clemente García-Rizo, Benedicto Crespo-Facorro, José Antonio Monreal, Diego Pala. Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis. Schizophrenia research. vol 222. 2021-05-18. PMID:32507371. |
we aimed to examine the evidence from open-label studies and randomized clinical trials (rcts) that studied four prolactin-lowering therapeutic strategies in people with psychotic disorders and hyperprolactinaemia: 1) switching to prolactin-sparing antipsychotics; 2) adding aripiprazole; 3) adding dopamine agonists; and 4) adding metformin. |
2021-05-18 |
2023-08-13 |
Not clear |
| Manuel Glauco Carbone, Claudia Tagliarini, Filippo Della Rocca, Walter Flamini, Giovanni Pagni, Beniamino Tripodi, Donatella Marazziti, Icro Maremman. Protracted Hiccups Induced by Aripiprazole and Regressed after Administration of Gabapentin. Case reports in psychiatry. vol 2021. 2021-05-14. PMID:33976948. |
it is probable that aripiprazole, prescribed at a low dosage (<7.5 mg/day), would act as a dopamine agonist by stimulating d |
2021-05-14 |
2023-08-13 |
Not clear |
| Michael M C Wong, Albert K K Chung, Timothy M H Yeung, David T W Wong, C K Lee, Eric Lai, Gloria F Y Chan, Gregory K L Mak, Jessica O Y Wong, Roger M K Ng, K L Tam, K Y Ma. Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong. Internal medicine journal. vol 50 Suppl 3. 2021-02-25. PMID:32985093. |
aripiprazole, a dopamine partial agonist, is a second-generation anti-psychotic that is widely used for the treatment of schizophrenia and other psychotic disorders. |
2021-02-25 |
2023-08-13 |
Not clear |
| Nobuhisa Kanahara, Hiroshi Kimura, Yasunori Oda, Fumiaki Ito, Masaomi Iy. Recent discussions on dopamine supersensitivity psychosis: Eight points to consider when diagnosing treatment-resistant schizophrenia. Current neuropharmacology. 2021-02-08. PMID:33550976. |
this review examines the data dealing with dopamine supersensitivity with the five themes of frequency, severity, withdrawal studies, switching to aripiprazole, and tardive dyskinesia. |
2021-02-08 |
2023-08-13 |
Not clear |
| Matheus Libarino-Santos, Ana Catherine Gomes de Santana Santos, Elisangela G Cata-Preta, Thaísa Barros-Santos, Nina Rosa Nunes Brandão, Aurea Lorena Nunes Borges, Renan Santos-Baldaia, André W Hollais, Marilia A Baldaia, Laís F Berro, Eduardo A V Marinho, Roberto Frussa-Filho, Alexandre J Oliveira-Lim. Role of the treatment environment in the effects of aripiprazole on ethanol-induced behavioral sensitization and conditioned place preference in female mice. Drug and alcohol dependence. vol 208. 2021-01-18. PMID:31954952. |
evidence suggests that aripiprazole, a partial dopamine d2 and serotonin 5-ht1a receptor agonist and 5-ht2a receptor antagonist, show significant efficacy in reducing alcohol use. |
2021-01-18 |
2023-08-13 |
mouse |
| Tinkara Pirc Marolt, Barbara Kramar, Klara Bulc Rozman, Dušan Šuput, Irina Milisa. Aripiprazole reduces liver cell division. PloS one. vol 15. issue 10. 2020-12-08. PMID:33104743. |
effects of aripiprazole on dopamine regulation are being tested as a treatment for patients with a dual diagnosis of schizophrenia and addictions, often cocaine dependence. |
2020-12-08 |
2023-08-13 |
Not clear |
| Francesca Forno, Yossi Maatuf, Shatha Boukeileh, Priya Dipta, Mohamed Mahameed, Odai Darawshi, Vitor Ferreira, Patricia Rada, Irma García-Martinez, Einav Gross, Avi Priel, Ángela M Valverde, Boaz Tiros. Aripiprazole Cytotoxicity Coincides with Activation of the Unfolded Protein Response in Human Hepatic Cells. The Journal of pharmacology and experimental therapeutics. vol 374. issue 3. 2020-11-05. PMID:32554435. |
our study highlights a new mechanism of aripiprazole that is not related to its effect on dopamine signaling. |
2020-11-05 |
2023-08-13 |
mouse |
| Joshua S Frankel, Thomas L Schwart. Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole. Therapeutic advances in psychopharmacology. vol 7. issue 1. 2020-10-01. PMID:28101322. |
brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole. |
2020-10-01 |
2023-08-13 |
Not clear |
| Shigenori Tadokoro, Naho Nonomura, Nobuhisa Kanahara, Kenji Hashimoto, Masaomi Iy. Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 15. issue 1. 2020-10-01. PMID:28138118. |
reduction of severity of recurrent psychotic episode by sustained treatment with aripiprazole in a schizophrenic patient with dopamine supersensitivity: a case report. |
2020-10-01 |
2023-08-13 |
Not clear |
| Eiji Kirin. Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29209406. |
aripiprazole (apz), a dopamine d2 partial agonist, has a unique pharmacological profile and few side effects. |
2020-10-01 |
2023-08-13 |
Not clear |
| Eva Ceskova, Petr Silha. Novel treatment options in depression and psychosis. Neuropsychiatric disease and treatment. vol 14. 2020-10-01. PMID:29559781. |
two new partial dopamine agonists, brexpiprazole and cariprazine, are now available in addition to aripiprazole. |
2020-10-01 |
2023-08-13 |
Not clear |
| Andreas Schreiner, Paul Bergmans, Pierre Cherubin, Ludger Hargarte. The effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole. Therapeutic advances in psychopharmacology. vol 7. issue 2. 2020-09-30. PMID:28255435. |
treatment with aripiprazole may be associated with benefits on negative symptoms and functioning given its partial agonism to the dopamine d |
2020-09-30 |
2023-08-13 |
Not clear |
| Moritz Schübler, Bassem Sadek, Tim Kottke, Lilia Weizel, Holger Star. Synthesis, Molecular Properties Estimations, and Dual Dopamine D Frontiers in chemistry. vol 5. 2020-09-30. PMID:28955709. |
synthesis, molecular properties estimations, and dual dopamine d neurleptic drugs, e.g., aripiprazole, targeting the dopamine d |
2020-09-30 |
2023-08-13 |
Not clear |
| Gulen Guler, Meryem Ozlem Kutuk, Halil Kar. Amenorrhea as a Side Effect of Low Dose Aripiprazole: An Adolescent Case. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 16. issue 3. 2020-09-30. PMID:30121986. |
hyperprolactinemia is one of major side effects of treatment with antipsychotics, but aripiprazole is known as a dopamine stabilizer antipsychotic which can be used to improve hyperprolactinemia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Lourdes Aguilar, Carolina Lorenzo, Raquel Fernández-Ovejero, Carlos Roncero, Angel L Montej. Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin. Frontiers in pharmacology. vol 10. 2020-09-30. PMID:30949057. |
we report on a patient with tardive dyskinesia (tdk) treated with aripiprazole, a third-generation antipsychotic with partial d2 agonist-antagonist activity at both the dopamine and serotonin receptors. |
2020-09-30 |
2023-08-13 |
Not clear |
| Hyung Jun Choi, Soo Jung Im, Hae Ri Park, Subin Park, Chul-Eung Kim, Seunghyong Ry. Long-term Effects of Aripiprazole Treatment during Adolescence on Cognitive Function and Dopamine D2 Receptor Expression in Neurodevelopmentally Normal Rats. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 3. 2020-09-30. PMID:31352706. |
long-term effects of aripiprazole treatment during adolescence on cognitive function and dopamine d2 receptor expression in neurodevelopmentally normal rats. |
2020-09-30 |
2023-08-13 |
rat |
| Hyung Jun Choi, Soo Jung Im, Hae Ri Park, Subin Park, Chul-Eung Kim, Seunghyong Ry. Long-term Effects of Aripiprazole Treatment during Adolescence on Cognitive Function and Dopamine D2 Receptor Expression in Neurodevelopmentally Normal Rats. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 3. 2020-09-30. PMID:31352706. |
this study aimed to investigate the long-term effects of aripiprazole treatment during adolescence on behavior, cognitive function, and dopamine d2 receptor (d2r) expression in adult rats. |
2020-09-30 |
2023-08-13 |
rat |
| Lígia Castanheira, Elsa Fernandes, Pedro Levy, Ricardo Coentr. Aripiprazole-induced Hepatitis: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 4. 2020-09-28. PMID:31671495. |
aripiprazole is an atypical antipsychotic that acts as a partial agonist of dopamine type 2 receptors as well as 5-ht1a receptors. |
2020-09-28 |
2023-08-13 |
Not clear |
| Maria-Ioanna Stefanou, Debora Vittore, Ines Wolz, Stefan Klingberg, Dirk Wildgrube. Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia. Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32425825. |
although hypersexuality has been acknowledged as a possible side effect of antipsychotic treatment with partial dopamine agonists, including aripiprazole, only very few cases of olanzapine-associated hypersexuality have been reported in the literature. |
2020-09-28 |
2023-08-13 |
Not clear |